Here, we aim to investigate the potential modulating effects of the DAT1 10/10 genotype on these brain changes in a subsample of 15 PD patients and 30 matched healthy controls, drawn from a larger cohort, who were genotyped and underwent fMRI whilst performing a monetary incentive delay task (17, 18). Here, SLC6A3 is linked to Parkinson disease.